RE:RE:RE:RE:RE:RE:RE:I think its probably all hypeStock picker: have you considered the possibility that one of the 60 or so drugs from amco, one is an upcoming real winner and only a previliged few have access to that info. Its not important what something is worth, it's what someone is willing to pay for it that matters. Cxr overpaid for amco, blackstone will overpay for Cxr. There are a lot of factors unknown to the retail investors.